术后早期引流液淀粉酶在风险分层患者中促进定制化胰切除术后引流管理和加速出院
本研究纳入174例胰十二指肠切除术或远端胰腺切除术患者,术前按胰瘘风险分为低危胰十二指肠切除、高危胰十二指肠切除和远端胰腺切除三组,通过ROC分析确定各组的引流液淀粉酶阈值以排除B/C级术后胰瘘。结果显示各组阈值独特,低危组DFA1≤661或DFA3≤141,高危组DFA1≤136或DFA3≤93,远端胰腺切除组DFA1<49或DFA3<26,均可100%敏感排除B/C级胰瘘,而通用DFA1<5000 U/L的敏感性仅57%。
要点
- 术前风险分层可确定组特异性DFA1/DFA3阈值以安全拔管。
- 通用DFA1<5000 U/L在胰十二指肠切除中敏感性仅57%。
- 低危胰十二指肠切除组B/C级胰瘘发生率3%,高危组37%。
核心结论
- 术前风险分层产生独特的DFA1/DFA3阈值以排除B/C级术后胰瘘,允许安全拔管和加速出院。
- 建议采用机构特异性DFA值而非基于国家数据库的通用阈值,并针对三种可复制的胰瘘风险路径定制。
研究设计与样本
- 回顾性研究,纳入2016年10月至2018年4月间174例接受胰十二指肠切除术或远端胰腺切除术且检测DFA1/DFA3的患者。
- 患者术前风险分层为低危胰十二指肠切除(n=78,45%)、高危胰十二指肠切除(n=51,29%)和远端胰腺切除(n=45,26%)。
- 采用受试者工作特征分析确定排除国际胰腺外科研究组B/C级术后胰瘘的临床相关敏感性阈值。
主要发现
- B/C级术后胰瘘发生率:低危胰十二指肠切除3%(n=2),高危胰十二指肠切除37%(n=19),远端胰腺切除24%(n=11)。
- 低危vs高危胰十二指肠切除P < .001,低危胰十二指肠切除vs远端胰腺切除P = .004,高危胰十二指肠切除vs远端胰腺切除P = .25。
- 胰十二指肠切除患者B/C级胰瘘总体发生率为16%(n=21)。
- 在胰十二指肠切除中,DFA1 ≤ 136或DFA3 ≤ 93可以100%敏感性排除B/C级胰瘘。
- DFA1 < 5000 U/L在胰十二指肠切除后排除B/C级胰瘘的敏感性仅为57%。
关键数值与推荐
- 低危胰十二指肠切除:DFA1 ≤ 661或DFA3 ≤ 141可100%敏感性排除B/C级胰瘘。
- 高危胰十二指肠切除:DFA1 ≤ 136或DFA3 ≤ 93可100%敏感性排除B/C级胰瘘。
- 远端胰腺切除:DFA1 < 49或DFA3 < 26可100%敏感性排除B/C级胰瘘。
临床怎么用
- 根据术前风险分层路径,采用相应的DFA1/DFA3阈值来安全地早期拔除引流管并考虑加速出院。
- 避免使用通用的DFA1<5000 U/L阈值,因其在胰十二指肠切除中敏感性低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: First postoperative day drain fluid amylase (DFA1) <5000 U/L is commonly used for early drain removal. We manage patients with risk-stratified pancreatectomy care pathways determined preoperatively by risk for postoperative pancreatic fistula. We hypothesized that preoperative risk stratification would yield unique DFA1/DFA3 cutoffs for safe early drain removal. METHODS: Patients with DFA1/DFA3 values after pancreaticoduodenectomy or distal pancreatectomy were identified. Patients were risk stratified as "low-risk pancreaticoduodenectomy," "high-risk pancreaticoduodenectomy," or "distal pancreatectomy." Receiver operator characteristic analyses yielded clinically relevant sensitivity thresholds for International Study Group on Pancreatic Surgery grade B/C postoperative pancreatic fistulas. RESULTS: From October 2016 to April 2018, 174 patients were preoperatively stratified as low-risk pancreaticoduodenectomy (n = 78, 45%), high-risk pancreaticoduodenectomy (n = 51, 29%), and distal pancreatectomy (n = 45, 26%). B/C postoperative pancreatic fistulas developed in 3% (n = 2) of low-risk pancreaticoduodenectomies, 37% (n = 19) of high-risk pancreaticoduodenectomies, and 24% (n = 11) of distal pancreatectomies (low- vs high-risk pancreaticoduodenectomy P < .001, low-risk pancreaticoduodenectomy versus distal pancreatectomy P = .004, high-risk pancreaticoduodenectomy versus distal pancreatectomy P = .25). B/C postoperative pancreatic fistulas occurred in 16% (n = 21) pancreaticoduodenectomy patients (high- + low-risk pancreaticoduodenectomy), and B/C postoperative pancreatic fistulas were excluded in pancreaticoduodenectomy with 100% sensitivity if DFA1 ≤ 136 or DFA3 ≤ 93. DFA1 < 5000 excluded B/C postoperative pancreatic fistulas with only 57% sensitivity after pancreaticoduodenectomy. Exclusion of B/C postoperative pancreatic fistulas occurred with 100% sensitivity if DFA1 ≤ 661 or DFA3 ≤ 141 in low-risk pancreaticoduodenectomy patients, DFA1 ≤ 136 or DFA3 ≤ 93 in high-risk pancreaticoduodenectomy patients, and DFA1 < 49 or DFA3 < 26 in distal pancreatectomy patients. CONCLUSION: Preoperative risk stratification results in unique DFA1/DFA3 thresholds to exclude B/C postoperative pancreatic fistulas, thus allowing for safe drain removal and potential for accelerated discharge. Rather than applying generic DFA cutoffs based on national databases, we propose institution-specific DFA1 and DFA3 values tailored to 3 replicable postoperative pancreatic fistula-risk pathways.
引用
- Newhook TE, Vega EA, Vreeland TJ, et al. Early postoperative drain fluid amylase in risk-stratified patients promotes tailored post-pancreatectomy drain management and potential for accelerated discharge. Surgery. 2019. PMID: 31727324. doi:10.1016/j.surg.2019.09.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。